In other news, the 13d group that wanted to take over our company included management in the company ElectroCore (ticker ECOR). With an approved treatment device, their share price has dropped down from $20.
Yesterday's drop was 19.89% to $0.2799, after the ECOR board approved the 1 for 15 reverse split, effective with today's trading 2/15/23.
Hope we dodged the mismanagement bullet by keeping 13d out.